Investigators identified a chemokine/chemokine receptor mismatch for osteosarcoma (i.e., osteosarcomas secrete chemokines for which CAR T cells do not express receptors). The researchers modified CAR ...
US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant, PIK3CA-Mutated, Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor ...
Osteosarcoma is a type of bone cancer. It can develop at any age, but most cases occur during childhood, early adolescence, and young adulthood. In young people, osteosarcoma tends to develop in the ...
Scientists at St. Jude Children’s Research Hospital identified chemokines expressed by osteosarcoma that improved CAR T-cell homing, with implications for immunotherapy development (MEMPHIS, Tenn. – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results